Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
Date:7/14/2008

d other current assets 1,208,000 1,188,000

Total current assets 19,843,000 19,898,000

PROPERTY:

Leasehold improvements 669,000 646,000

Laboratory equipment 4,140,000 3,533,000

Furniture, fixtures and computer equipment 919,000 873,000

5,728,000 5,052,000

Less accumulated depreciation and

amortization (3,670,000) (3,212,000)

Property, net 2,058,000 1,840,000

Other assets 1,156,000 1,259,000

TOTAL ASSETS $23,057,000 $22,997,000

-continued-

PEREGRINE PHARMACEUTICALS, INC.

CONSOLIDATED BALANCE SHEETS

AS OF APRIL 30, 2008 AND 2007 (continued)

2008 2007

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:

Accounts payable $2,060,000 $1,683,000

Accrued clinical trial site fees 237,000 228,000

Accrued legal and accounting fees 450,000 392,000

Accrued royalties and license fees 222,000 337,000

Accrued payroll and related costs 1,084,000 874,000

Notes payable, current portion - 379,000

Capital lease obligation, current portion 22,000 17,000

Deferred revenue 2,196,000 1,060,000

Customer deposits 838,000 585,000

Other current liabilities 331,000 300,000

Total current liabilities 7,440,000 5,855,000 '/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
2. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
3. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
4. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
5. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
6. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
7. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
9. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
10. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
11. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... October 20, 2014 , A ... disorders and the delivery of care has revealed changing ... worrying inequalities in the provision of healthcare services across ... commissioned by United European Gastroenterology (UEG), have been announced ... public awareness of the burden of GI disorders across ...
(Date:10/20/2014)... 2014 OncLive® is ... Center at Thomas Jefferson University has joined its ... Strategic Alliance Partnership program, the Sidney Kimmel Cancer ... raise awareness of the Center’s cutting-edge research programs, ... Clinicians and other health care professionals from the ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The Latin ... the market in Latin America with analysis and forecast ... in 2013, and is expected to reach $2,366.8 million ... to 2018. , Browse through the TOC of the ... idea of the in-depth analysis provided. It also provides ...
(Date:10/19/2014)... 2014 The Asia-Pacific Bromine Market ... Asia-Pacific with analysis and forecast of revenue. , ... Bromine Market report, to get an idea of ... glimpse of the segmentation in the Asia-Pacific bromine ... figures. , http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine ...
Breaking Biology Technology:Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... NEW DELHI, India, August 29, 2011 , ... in September Bring focus on auto components, home ... on business opportunities for Indian SMEs at these global platforms ... a huge opportunity in global markets for Indian Small and ...
... Corporation (NYSE: WAT ) today recognized ... Research Institute (TGen) as a Waters Center ... In particular, Waters recognized Dr. Konstantinos Petritis, Head of ... leadership in the research of proteomics and biomarker discovery ...
... 2011 Emmy® and Tony® award-winning actress Blythe Danner ... Act 2 Reduce Fractures™, an educational campaign for women ... this year, Danner was diagnosed with postmenopausal osteoporosis at ... like her to educate themselves, take action and speak ...
Cached Biology Technology:IndiaMART.com to Step Up B2B Matchmaking at Global Trade Events 2IndiaMART.com to Step Up B2B Matchmaking at Global Trade Events 3Center for Proteomics at the Translational Genomics Research Institute (TGen) Selected as Waters Center of Innovation 2Center for Proteomics at the Translational Genomics Research Institute (TGen) Selected as Waters Center of Innovation 3Center for Proteomics at the Translational Genomics Research Institute (TGen) Selected as Waters Center of Innovation 4Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 2Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 3Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 4Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 5Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 6Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 7
(Date:10/15/2014)... University Mainz (JGU) as a full member, ensuring ... a significant nationwide standing in the field of ... Gutenberg University Mainz as a full member of ... and international competition for the best minds and ... proud that Mainz University has been recognized as ...
(Date:10/15/2014)... Oct. 15, 2014   Neurotechnology , a ... the availability of the VeriLook Surveillance 3.0 ... provides real-time biometric face identification using live video ... cameras. The new version not only identifies faces ... from objects while they are moving through the ...
(Date:10/14/2014)... One of the planet,s leading questions is how to ... increasingly variable climate. The Food and Agriculture Organization of ... 70% over the next 40 years to feed a ... of the necessary rise in food production. Plants—grains, ... by supporting livestock. Current research must tap into ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
... "Salt-loving algae could be the key to the successful ... means of recycling atmospheric carbon dioxide", Professor John Cushman ... General Microbiology meeting at Heriot-Watt University, Edinburgh, today (10 ... is the lack of adequate feedstocks, soybeans and corn, ...
... In Arctic areas, climate change is progressing faster than in ... Helsinki have participated in two new studies indicating that the ... are in jeopardy, as global warming causes species from southern ... of the original species. The renowned Science ...
... Research Council (ERC) expects to fund some 240 top ... This new wave of grantees follows the 299 researchers ... in 2007. In total, 2503 proposals were submitted ... Lehtonen,s research group is studying the kidney glomerular ultrafiltration ...
Cached Biology News:The change in Arctic nature foreshadows the global environment of the future 2ERC Starting Grant for the researcher of kidney diseases 2